TAILIEUCHUNG - BURUNDI GLOBAL HEALTH INITIATIVE STRATEGY 2011-2015

The strategy promotes a long-term, sustainable HIV response through strengthening health and community systems, tackling the social determinants of health that both drive the epidemic and hinder the response, and protecting and promoting human rights and promoting gender equity as essential elements of the health sector response. It strengthens integration between HIV and other health services, improving both impact and efficiency. It calls on the world to build on the collaboration, innovation and investment that have forged hard-won progress to date, establishing the foundation for success over the next five years. Figure 1 depicts the elements of the strategy schematically | BURUNDI GLOBAL HEALTH INITIATIVE STRATEGY 2011-2015 September 2011 Introduction This document outlines a strategy for the USG s Global Health Initiative GHI in Burundi for the period 2011-2015. It includes a description of the overall health situation in Burundi the Government of Burundi s GOB health priorities and its budget constraints and provides an overview of planned . Government USG health programming based on these priorities. The strategy includes an initial strategic framework action plan management plan and monitoring and evaluation M E framework by which to implement activities and monitor progress against defined GHI outcomes and impacts. The development process of this strategy went through various stages. After having received GHI guidance documents in March 2011 an in-country USG team composed of relevant USAID and DOD personnel began consultation meetings to agree on how the process would be conducted. Key documents including GOB s National Health Development Plan NHDP 20112015 were referenced and have been used to design the strategy as have data from the 2010 Demographic and Health Survey DHS . During the strategy development phase the Ambassador to Burundi and USAID Country Representative met the Minister of Public Health and Fight against AIDS MOHA to discuss the GHI framework. The Minister was - and remains - supportive of GHI principles which emphasize the importance of aligning with country-led plans country ownership sustainability leveraging and efficiency. The Minister has since been consulted on subsequent versions of the strategy and provided important feedback and input. Before finalizing the GHI strategy document the USG Burundi team shared it with other stakeholders involved in the health sector in Burundi. Their comments have been integrated into the current strategy document. They were appreciative of the emphasis made on country ownership alignment with country-led plans and enhanced coordination with other donors. The .

• Sức khỏe trẻ em
• Genetic Polymorphisms
• Molecular Pathogenesis
• Pathogenesis of Endometriosis
• Therapeutic Approach
• Approach to Endometriosis
• Endometriosis
• Additive genetic effect
• Litter size
• Additive genetic effects of RNF4
• IGF2 polymorphisms
• Landrace and yorkshire sows
• BMC Cancer
• Gastric cancer
• Vascular endothelial growth factor
• Adjuvant chemotherapy
• Genetic variants
• OPN polymorphisms
• Kaplan Meier method
• BMC Pulmonary Medicine
• Lower respiratory tract infection
• Recurrent wheezing
• Respiratory viruses
• Coronary artery disease
• Genetic polymorphism
• Itercellular adhesion molecule 1
• Chronic inflammatory disease
• Single nucleotide polymorphisms
• Lung cancer
• Tobacco smoking
• Nicotine metabolism
• CYP2A6 genetic polymorphisms
• HMGB1 polymorphisms
• Breast cancer
• Single nucleotide polymorphism
• High mobility group box protein 1
• HER2 enriched
• Type 2 diabetes mellitus
• Cytotoxic T lymphocyte associated antigen 4
• Cytokine overproduction
• Counter regulatory molecules
• T2DM etiology
• Mitotic kinases
• Cancer susceptibility
• Chromosomal instability
• Genetic testing
• Personalised screening
• Bladder cancer
• Plasma levels
• Anti inflammatory properties
• Investigated polymorphisms
• IL 27 gene polymorphisms
• Breast density
• Genetic risk factors
• Race stratified
• Tissue factor pathway
• Activated protein C resistance
• Genotype phenotype correlations
• Factor V Leiden
• Hepatocellular carcinoma
• High resolution melting
• Serum cholinesterase
• Luận án Tiến sĩ
• Luận án Tiến sĩ Hóa học
• Polymorphisms mutations
• Genetic variants database
• Kinh Vietnamese
• Summary of Biology Doctoral Thesis
• Biology Doctoral Thesis
• Mutational polymorphisms
• Genetic diversity
• Individual medicine
• BMC Genetics
• Drug responses
• Pharmacokinetics genes
• Non small cell lung carcinoma
• Epidermal growth factor receptor
• Cell cycle
• Real Time PCR System
• Cytochrome P450
• TaqMan PCR
• Dried saliva
• Japanese population
• Genetic analysis
• Drug metabolism
• BMC Biotechnology
• Genotype identity
• Genetic heterogeneity
• Bioinformatic handling
• Transgenic plants
• Childhood cancer
• Acute lymphoblastic leukemia
• Chemotherapy related cardiotoxicity
• BMC Bioinformatics
• Feature selection
• Information gain
• Genetic algorithm
• Support vector machine
• CHI3L1 protein
• Cohort study
• Cord blood
• Genetic association study
• Genetic variation
• YKL 40 protein
• BMC Genomics
• Capsicum spp
• Chile peppers
• Linkage disequilibrium
• Population structure
• Single nucleotide polymorphism markers
• Triticum aestivum L